Front Range Biosciences is an agricultural biotech company that specializes in tissue culture propagation breeding of high-value crops at industrial scale to improve consistency and efficiency for clone and seed production.
Front Range Biosciences provides hemp, coffee, and high-value crop growers with high-performing plants and seed, by combining the best practices in agriculture with modern science, through our Clean Stock® Program.
Front Range Biosciences was founded in 2015 by Nick Hofmeister and Dr. Jon Vaught. The company has its headquarter based in Lafayette, Colorado.
Front Range Biosciences' goal is to serve as a reliable source for high-value crop growers through innovation, transparency, and science-based results. In an industry that is ever-changing and evolving, we pride ourselves on open communication and adaptability. It enables a grower to reduce crop loss due to pathogens, quickly sex a plant, and develop new strains of plants that have the most valuable commercial properties.
Front Range Biosciences has developed the first Clean StockÂ® program for cannabis and hemp and has an advanced breeding program for identifying and improving commercially relevant traits.
FRB has global reach through facilities in Colorado, California, and Wisconsin, and partnerships with the University of California Davis and the Center for Research in Agricultural Genomics in Barcelona, Spain.
FRB is backed by Militello Capital, Welcan Capital, AFI Capital, Phyto Partners, Harvard Business School Alumni Angels of New York, New York Angels, Altitude Investment Management, Sand Hill Angels XVI, LLC, Arcadian Capital Management, Halley Venture Partners LP and Salveo Capital among others. The company raised $8.5M in its latest "Series B" financing on Sep 16, 2019. This brings FRB's total funding to $23.1M to-date.